ACMR ACM Research
ACM Research earnings company data as of 1:01 PM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 5 Nov | EPS | 0.41 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by ACMR's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- None no sales outside a trading plan
- $51.2M sold by 8 insiders under 10b5-1 plans
-
David H Wang See RemarksPlanned sale$10.6M 140,000 shares at $75.93 15% of stakeTraded Sep 8–9 Filed Sep 10
-
Mark McKechnie See RemarksPlanned sale$4.3M 55,199 shares at $77.27 98% of stakeTraded Aug 20 Filed Aug 21
-
Haiping Dun DirectorPlanned sale$406K 5,000 shares at $81.13 100% of stakeTraded Aug 18 Filed Aug 20
-
Sotheara Cheav See remarksPlanned sale$1.6M 18,750 shares at $84.58 16% of stakeTraded Jun 4–5 Filed Jun 5
-
David H Wang See RemarksPlanned sale$8.8M 100,002 shares at $88.35 11% of stakeTraded Jun 3–4 Filed Jun 5
-
Haiping Dun DirectorPlanned sale$331K 5,000 shares at $66.22 100% of stakeTraded May 19 Filed May 21
-
Charles C Pappis DirectorPlanned sale$260K 5,000 shares at $52.00 100% of stakeTraded Apr 17 Filed Apr 21
-
Mark McKechnie See RemarksPlanned sale$4.5M 98,551 shares at $45.58 99% of stakeTraded Mar 12 Filed Mar 13
-
David H Wang See RemarksPlanned sale$5.2M 110,000 shares at $46.86 12% of stakeTraded Mar 11–12 Filed Mar 13
-
Tracy Liu DirectorPlanned sale$2.9M 60,000 shares at $47.51 35% of stakeTraded Mar 10–11 Filed Mar 12
-
Haiping Dun DirectorPlanned sale$217K 5,000 shares at $43.47 100% of stakeTraded Mar 9 Filed Mar 11
-
Charles C Pappis DirectorPlanned sale$250K 5,000 shares at $50.09 100% of stakeTraded Mar 5 Filed Mar 9
-
Lisa Feng See remarksPlanned sale$1.4M 30,000 shares at $48.04 38% of stakeTraded Mar 5–6 Filed Mar 9
-
Mark McKechnie See RemarksPlanned sale$1.1M 31,250 shares at $34.93 97% of stakeTraded Dec 4–8 Filed Dec 8, 2025
-
David H Wang See RemarksPlanned sale$4.4M 130,000 shares at $33.55 14% of stakeTraded Dec 3–4 Filed Dec 5, 2025
Also filed in the last 12 months, not counted as buying or selling: 29 option exercises and 1 gift.
SEC filings
Recent issuer filings from EDGAR, 22 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 424B5 | Filing Doc | ||
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.